Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

4.950 -0.130 (-2.56%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	690,452
Open	5.080
Bid (Size)	4.900 (100)
Ask (Size)	5.260 (3,900)
Prev. Close	5.080
Today's Range	4.875 - 5.110
52wk Range	4.480 - 13.22
Shares Outstanding	33,981,877
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook ↗

July 10, 2026

RxSight (NASDAQ:RXST) reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with...

Via MarketBeat

Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

July 10, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Performance

YTD	-52.3%	-52.3%
1 Month	+7.6%	+7.6%
3 Month	-27.5%	-27.5%
6 Month	-44.0%	-44.0%
1 Year	-41.5%	-41.5%

More News

Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

July 08, 2026

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

July 07, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction ↗

May 06, 2026

Via Chartmill

RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares ↗

February 25, 2026

Via Chartmill

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

July 06, 2026

From RxSight, Inc.

Via GlobeNewswire

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

July 06, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

May 19, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight (RXST) Q1 2026 Earnings Transcript ↗

May 12, 2026

Via The Motley Fool

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

May 06, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

April 29, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

April 22, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

April 02, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight (RXST) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

Via The Motley Fool

RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance

February 25, 2026

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

February 11, 2026

From RxSight, Inc.

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

January 11, 2026

From RxSight, Inc.

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

January 02, 2026

From RxSight, Inc.

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

RxSight, Inc. Announces Chief Financial Officer Transition

December 22, 2025

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

November 20, 2025

From RxSight, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?

Yes, RxSight, Inc. - Common Stock is publicly traded.

What exchange does RxSight, Inc. - Common Stock trade on?

RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for RxSight, Inc. - Common Stock?

The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market

What is the current price of RxSight, Inc. - Common Stock?

The current price of RxSight, Inc. - Common Stock is 4.950

When was RxSight, Inc. - Common Stock last traded?

The last trade of RxSight, Inc. - Common Stock was at 07/10/26 04:00 PM ET

What is the market capitalization of RxSight, Inc. - Common Stock?

The market capitalization of RxSight, Inc. - Common Stock is 168.21M

How many shares of RxSight, Inc. - Common Stock are outstanding?

RxSight, Inc. - Common Stock has 168M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.